Navigation Links
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
Date:12/17/2009

es and other governmental regulatory bodies, including the FDA's review of any filings we make in connection with the treatment protocol; delays in the FDA's or other health regulatory authorities' approval of any applications we file or refusals to approve such filings; refusals by such regulatory authorities to approve the marketing and sale of a drug product even after acceptance of an application we file for any such drug product; the identification of lead compounds; the risk that we may fail to satisfy certain conditions relating to grants we have received from the Office of the Chief Scientist of Israel's Ministry of Industry and Trade which may lead to our being required to refund grants previously received together with interest and penalties; the risk that the Office of the Chief Scientist may not deliver to us all of the funds awarded to us; uncertainties related to the ability to attract and retain partners for our technologies and products under development; and other factors described in our filings with the Securities and Exchange Commission. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced or late-stage clinical trials, even after obtaining promising earlier trial results or in preliminary findings for such clinical trials. Further, even if favorable testing data is generated by clinical trials of drug products, the FDA may not accept or approve an NDA filed by a pharmaceutical or biotechnology company for such drug product. Failure to obtain FDA approval of any of our drug candidates in a timely manner, if at all, will severely undermine our business and results of operation by reducing our potential marketable products and our ability to generate corresponding product revenues. Under our approved treatment protocol, taliglucerase alfa might be provided only to a limited number of patients and only for a limited time. The FDA's approval of the treatment protocol or the fast track design
'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
2. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
3. CVS Caremark Names New Chief Human Resources Officer
4. Cardinal Health Names Carrie Cox to Board of Directors
5. Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO
6. The Deal Names Abbott Top Dealmaker for Second Consecutive Year
7. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
8. AMD LASERS Names Dr. James Jesse as Medical Director
9. Arcadia Resources Names Stephen Goldsmith to Board of Directors
10. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
11. Codexis Names Fernando Valle Research Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
(Date:1/22/2015)... , Jan. 22, 2015  Profil Institute for Clinical Research, ... and obesity, announced today a new textbook,  Translational Research ... by Springer, a leading global scientific publisher. ... illustrate techniques for use in early phase clinical studies ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... , ATLANTA , Jan. ... market leader in automated revenue integrity solutions that improve healthcare ... first customer. , Supplies ChargeLink™ is a ... for chargeable supplies. It does this by establishing and maintaining ...
... R&D Program Targets Opportunities to Improve Glucose Control and Help People ... and FRANKLIN LAKES, N.J. , Jan. 19 ... and Company) (NYSE: BDX ) announced today an innovative ... developing novel insulin delivery products to enhance the use of insulin ...
Cached Medicine Technology:Craneware's New Product Reduces Supply Chain Revenue Leakage 2Craneware's New Product Reduces Supply Chain Revenue Leakage 3Craneware's New Product Reduces Supply Chain Revenue Leakage 4JDRF and BD Collaborate to Improve Insulin Pump Delivery 2JDRF and BD Collaborate to Improve Insulin Pump Delivery 3JDRF and BD Collaborate to Improve Insulin Pump Delivery 4JDRF and BD Collaborate to Improve Insulin Pump Delivery 5
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
(Date:1/22/2015)... 22, 2015 As interest in the value ... gains momentum worldwide, Rev. Eric J. Hall , president ... (HCCN), will be the keynote speaker on January 27 ... public health system. , The conference, “Hope and Resilience: Innovative ...
(Date:1/22/2015)... 22, 2015 Compare-autoinsurance.org has released a new blog ... an auto insurance policy . , Some types of ... should check the newly released blog post to see if their ... dangerously damaged vehicles are some of the cars that cannot be ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... nation,s worst violators of,union rights, CHICAGO, Sept. 19 ... violence and repression when they try to exercise,their right ... land of the free,anti-union employers intimidate and even fire ... findings of a newly released annual survey by,a respected ...
... Delivered ... Office or their Smartphone, ALISO VIEJO, Calif., Sept. 19 ... that Century,City Doctors Hospital (CCDH), an acute-care facility located in ... Clinical,Information System (ICIS). ICIS delivers multiple data types from ...
... welcomed last night,s Senate passage of mental health ... the Senate,s version,when the panel considers the legislation ... is a strong measure that will advance the ... employers," said NRF Vice,President and Employee Benefits Policy ...
... plentiful this year, but inoculation rates are low, officials ... many Americans aren,t getting vaccinated for the flu, including ... workers -- U.S. health officials warned Wednesday. , "Despite ... still failing to protect a large proportion of people," ...
... Sept. 19 Activator Methods International,( http://www.activator.com ), ... 40 years, has formed an alliance,with three leading ... The series, designed to help doctors improve the ... 15th in St. Louis. "What,s new about ...
... to Offer Two-Way American Sign Language Support, ... who are deaf or hard of hearing can ... videophones and American Sign Language. The new ... is available here and in Maryland, Virginia and ...
Cached Medicine News:Health News:International Watchdog Group Singles Out Resurrection for Anti-Union Violations 2Health News:Century City Doctors Hospital Goes Live With Global Care Quest's ICIS Solution 2Health News:Retailers Welcome Senate Passage of Mental Health Parity Bill, Urge House to Adopt Senate Version at Subcommittee Markup 2Health News:More Americans Urged to Get Flu Shots 2Health News:More Americans Urged to Get Flu Shots 3Health News:New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nation's Chiropractic Care: Focus on the Patients 2Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 2Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 3Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 4Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 5Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 6Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 7
... imaging have changed dramatically over the past ... manufacturer of dedicated EP imaging systems that ... requirements. Our EP systems are fully ... needs of EP, Pacemaker and ICD procedures., ...
... called PrimeSuite, is a Web Browser-based ... Practice Management, Electronic Medical Record (EMR) ... meet the healthcare industrys demand for ... part of a suite of physician-centric ...
... Medical Records module is designed to ... and increase revenues. It creates and ... effort while it streamlines workflow, controls ... to patient care outcomes. NextGen EMR ...
... most successful EMR in the industry. ... improvements that deliver measurable returns. Examples ... our clients abound, from reducing avoidable ... They have realized significant financial benefits ...
Medicine Products: